Ignite Creation Date:
2024-05-05 @ 9:19 PM
Last Modification Date:
2024-10-26 @ 10:03 AM
Study NCT ID:
NCT00868361
Status:
TERMINATED
Last Update Posted:
2009-09-16
First Post:
2009-03-24
Brief Title:
A Study to Investigate the Absorption Metabolism and Excretion of Talampanel
Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Organization:
Teva Branded Pharmaceutical Products RD Inc
Study Overview
Official Title:
A Phase 1 Open-label Mass Balance Study to Investigate the Absorption Metabolism and Excretion of 14C-Talampanel Following Oral Administration to Healthy Male
Status:
TERMINATED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Poor recruitment of fast and slow acetylators
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to characterize the chemical breakdown and excretion of talampanel and its break down products in plasma feces and urine of healthy human volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None